A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC
Condition(s):Non-small Cell Lung CancerLast Updated:July 6, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung CancerLast Updated:July 6, 2021Not yet recruiting
Condition(s):Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationLast Updated:August 10, 2020Recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:April 16, 2019Unknown status
Condition(s):Ovarian Cancer; Chemotherapeutic ToxicityLast Updated:January 16, 2018Unknown status
Condition(s):Quality of LifeLast Updated:May 21, 2019Completed
Condition(s):Nonsquamous Nonsmall Cell Neoplasm of LungLast Updated:August 3, 2016Unknown status
Condition(s):Hepatic Metastasis of Colorectal CancerLast Updated:April 16, 2020Unknown status
Condition(s):Small Cell Lung CarcinomaLast Updated:July 1, 2020Unknown status
Condition(s):Advanced Gastric CancerLast Updated:September 7, 2023Active, not recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:April 26, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.